KFA
KITE

Kelleher Financial Advisors’s Kite Pharma, Inc. KITE Stock Holding History

Kelleher Financial Advisors’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-5,955
Closed -$273K – 227
2016
Q1 		$273K Buy
+5,955
New +$288K 0.15% 126

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Kelleher Financial Advisors's KITE Position: Q2 2016 in Review

Kelleher Financial Advisors sold out of Kite Pharma, Inc. (KITE) in Q2 2016, closing a stake of 5,955 shares — an estimated $273K sold.

Kelleher Financial Advisors first reported a position in KITE in Q1 2016 and held it in 1 quarter. The position peaked at $273K in Q1 2016. 173 funds tracked by Wall St. Rank hold KITE as of Q2 2016.

  • Kelleher Financial Advisors reported no remaining Kite Pharma, Inc. position as of Q2 2016 after selling out during the quarter.
  • Kelleher Financial Advisors sold 5,955 Kite Pharma, Inc. shares in Q2 2016, an estimated $273K.
  • Kelleher Financial Advisors first reported a position in Kite Pharma, Inc. in Q1 2016 and held it in 1 quarter.
  • Kelleher Financial Advisors's Kite Pharma, Inc. position peaked at $273K in Q1 2016.
  • 173 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q2 2016.

Based on Kelleher Financial Advisors's 13F filing for Q2 2016, filed 3 Aug 2016.